JANX | Janux Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	48.70 - 51.49
52 Week Range	5.65 - 65.60
Beta	3.58
Implied Volatility	107.12%
IV Rank	45.56%
Day's Volume	451,532
Average Volume	597,650
Shares Outstanding	52,164,500
Market Cap	2,602,486,905
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-06-11

Valuation
Profitability
Growth
Health
P/E Ratio	-56.69
Forward P/E Ratio	N/A
EPS	-0.88
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	69
Country	USA
Website	JANX

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.

JANX's peers: ADAG, CDXC, FENC, GHRS, GNFT, GNTA, HRMY, IMTX, INSM, IVA, MLYS, ELYM, ANEB, RZLT, KROS, EWTX, MOLN, MNOV, CSBR, CYT, AVTE, ACRV, ANTX, PHAR, PHVS, PRTC, PRTG, SLGL, NAMS, MLEC

*Chart delayed

Analyzing fundamentals for JANX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is strong. For more detailed analysis please see JANX Fundamentals page.

Watching at JANX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on JANX Technicals page.